FDA.reportPublic FDA data

ASCLERA 20 MG in 2 ML Injection

RxCUI
968183
RxNorm name
ASCLERA 20 MG in 2 ML Injection
Display name
ASCLERA 20 MG in 2 ML Injection
Full name
ASCLERA 20 MG in 2 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AscleraPOLIDOCANOLMethapharm, Incbb1f342b-5352-4059-a0b2-e60fd652fd282025-07-16Warnings, Adverse reactionsExact identifier
rxcui: 968183

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bb1f342b-5352-4059-a0b2-e60fd652fd28ASCLERA 20 MG in 2 ML Injection [PSN] · 2 ML polidocanol 10 MG/ML Injection [Asclera] [SBD] · 2 ML Asclera 10 MG/ML Injection [SY] · Asclera 1 % Injection [SY] · Asclera 20 MG per 2 ML Injection [SY]526These highlights do not include all the information needed to use Asclera ® Injection safely and effectively. See full prescribing information for Asclera. Asclera (polidocanol) Injection, for intravenous use Initial U.S. Approval: 201020250716